NASDAQ:OGI Organigram - OGI Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Organigram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.63 -0.01 (-1.56%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's Range$0.62▼$0.6550-Day Range$0.60▼$0.9952-Week Range$0.59▼$1.87Volume267,956 shsAverage Volume890,307 shsMarket Capitalization$198.66 millionP/E RatioN/ADividend YieldN/APrice Target$1.67 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Organigram MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside163.4% Upside$1.67 Price TargetShort InterestBearish2.12% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.04) to ($0.03) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.93 out of 5 starsMedical Sector815th out of 1,005 stocksPharmaceutical Preparations Industry392nd out of 486 stocks 3.5 Analyst's Opinion Consensus RatingOrganigram has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $1.67, Organigram has a forecasted upside of 163.4% from its current price of $0.63.Amount of Analyst CoverageOrganigram has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted2.12% of the outstanding shares of Organigram have been sold short.Short Interest Ratio / Days to CoverOrganigram has a short interest ratio ("days to cover") of 5.7.Change versus previous monthShort interest in Organigram has recently increased by 23.75%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldOrganigram does not currently pay a dividend.Dividend GrowthOrganigram does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for OGI. Previous Next 2.4 News and Social Media Coverage News SentimentOrganigram has a news sentiment score of 0.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Organigram this week, compared to 1 article on an average week.Search Interest32 people have searched for OGI on MarketBeat in the last 30 days. This is an increase of 68% compared to the previous 30 days.MarketBeat Follows8 people have added Organigram to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Organigram insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.09% of the stock of Organigram is held by insiders.Percentage Held by InstitutionsOnly 10.98% of the stock of Organigram is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Organigram are expected to grow in the coming year, from ($0.04) to ($0.03) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Organigram is -21.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Organigram is -21.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOrganigram has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Organigram (NASDAQ:OGI) StockOrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.Read More Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter. Email Address OGI Stock News HeadlinesMarch 13, 2023 | businesswire.comOrganigram Provides Edison JOLTS Product UpdateFebruary 27, 2023 | benzinga.comOrganigram Launches SHRED X Rip-Strip Hash Making It 'Easy To Roll Your Own Hash-Infused Pre-Rolls'March 26, 2023 | Weiss Ratings (Ad)Bank Accounts: Frozen!In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!January 30, 2023 | reuters.comOGI.TO - | Stock Price & Latest News | ReutersJanuary 26, 2023 | finance.yahoo.comOrganigram Provides NASDAQ Listing UpdateJanuary 13, 2023 | benzinga.comWhat Holds Value For Canadian Cannabis Company Organigram? Analyst OpinesJanuary 12, 2023 | finance.yahoo.comOrganiGram (OGI) Reports Q1 Loss, Misses Revenue EstimatesJanuary 12, 2023 | finance.yahoo.comOrganigram Reports Record First Quarter Fiscal 2023 ResultsMarch 26, 2023 | Weiss Ratings (Ad)Bank Accounts: Frozen!In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!January 3, 2023 | finance.yahoo.comOrganiGram (OGI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?December 16, 2022 | finance.yahoo.comOrganigram Holdings Inc. (NASDAQ:OGI) Q4 2022 Earnings Call TranscriptDecember 9, 2022 | ca.finance.yahoo.comStocks in play: Organigram Holdings Inc.November 28, 2022 | finance.yahoo.comOrganigram Reports Record Fourth Quarter and Full Year Fiscal 2022 ResultsNovember 23, 2022 | finance.yahoo.comOrganigram Launches HOLY MOUNTAIN to Further Support Its Strong Position in the Dried Flower and Hash CategoriesOctober 16, 2022 | finance.yahoo.comThe past three years for OrganiGram Holdings (TSE:OGI) investors has not been profitableOctober 13, 2022 | fool.com2 Pot Stocks That Could Set You Up for Life - The Motley FoolOctober 12, 2022 | nasdaq.comTilray Brands Stock Could Grow by 20 Times by 2030 - NasdaqOctober 6, 2022 | fool.comWhy Pot Stocks Like Canopy Growth and Organigram Surged Higher Today - The Motley FoolSeptember 15, 2022 | fool.com1 Surprising Stat That Could Help Jump-Start This Struggling Sector - The Motley FoolSeptember 14, 2022 | benzinga.comOrganiGram Holdings (NASDAQ:OGI), HEXO (NASDAQ:HEXO) – Want Exposure To The Canadian Recreational Cannabi - BenzingaSeptember 14, 2022 | seekingalpha.comNew congressional bill aims to empower small cannabis growers (NASDAQ:TLRY) - Seeking AlphaSeptember 8, 2022 | marketwatch.comQuebec and Alberta provinces reportedly won't allow sales of Mike Tyson's cannabis by Hexo - MarketWatchSeptember 1, 2022 | fool.comWhy Pot Stocks Are Going Up In Smoke Today - The Motley FoolAugust 31, 2022 | streetinsider.comCanadian Cannabis Stocks To Watch In September - StreetInsider.comAugust 18, 2022 | nasdaq.comOrganigram Holdings Inc. Common Shares (OGI)July 27, 2022 | streetinsider.comTop Canadian Cannabis Stocks To Watch Before August - StreetInsider.comJuly 14, 2022 | fool.comHere's What Moved Sundial Growers, Organigram, and Canopy Growth Stocks Today - The Motley FoolSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter. Email Address OGI Company Calendar Last Earnings1/12/2023Today3/26/2023Next Earnings (Estimated)4/11/2023Fiscal Year End8/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:OGI CUSIPN/A CIK1620737 Webwww.organigram.ca Phone(844) 644-4726FaxN/AEmployees841Year FoundedN/APrice Target and Rating Average Stock Price Forecast$1.67 High Stock Price Forecast$2.00 Low Stock Price Forecast$1.50 Forecasted Upside/Downside+163.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,230,000.00 Net Margins-4.97% Pretax Margin-5.41% Return on Equity-6.00% Return on Assets-5.30% Debt Debt-to-Equity RatioN/A Current Ratio4.71 Quick Ratio2.84 Sales & Book Value Annual Sales$111.27 million Price / Sales1.79 Cash FlowN/A Price / Cash FlowN/A Book Value$1.27 per share Price / Book0.50Miscellaneous Outstanding Shares313,940,000Free Float313,656,000Market Cap$198.66 million OptionableNot Optionable Beta0.88 Key ExecutivesBeena G. GoldenbergChief Executive Officer & DirectorNathalie BattenVice President-OperationsDerrick W. WestChief Financial OfficerGeoff RiggsChief Information OfficerTimothy EmbergChief Revenue OfficerKey CompetitorsZevra TherapeuticsNASDAQ:KMPHNature's Sunshine ProductsNASDAQ:NATRVera TherapeuticsNASDAQ:VERAALX OncologyNASDAQ:ALXOFulcrum TherapeuticsNASDAQ:FULCView All CompetitorsInstitutional OwnershipIntact Investment Management Inc.Bought 187,500 shares on 2/15/2023Ownership: 0.417%Morgan StanleySold 642,405 shares on 2/15/2023Ownership: 0.054%Millennium Management LLCSold 220,820 shares on 2/15/2023Ownership: 0.024%SIG North Trading ULCBought 14,000 shares on 2/15/2023Ownership: 0.000%Susquehanna International Group LLPSold 176,100 shares on 2/14/2023Ownership: 0.000%View All Institutional Transactions OGI Stock - Frequently Asked Questions Should I buy or sell Organigram stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Organigram in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OGI shares. View OGI analyst ratings or view top-rated stocks. What is Organigram's stock price forecast for 2023? 2 analysts have issued 1 year price targets for Organigram's shares. Their OGI share price forecasts range from $1.50 to $2.00. On average, they predict the company's share price to reach $1.67 in the next year. This suggests a possible upside of 163.4% from the stock's current price. View analysts price targets for OGI or view top-rated stocks among Wall Street analysts. How have OGI shares performed in 2023? Organigram's stock was trading at $0.80 on January 1st, 2023. Since then, OGI shares have decreased by 20.9% and is now trading at $0.6328. View the best growth stocks for 2023 here. When is Organigram's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 11th 2023. View our OGI earnings forecast. How were Organigram's earnings last quarter? Organigram Holdings Inc. (NASDAQ:OGI) announced its earnings results on Thursday, January, 12th. The company reported ($0.01) EPS for the quarter, meeting analysts' consensus estimates of ($0.01). The firm earned $32.16 million during the quarter, compared to analyst estimates of $32.63 million. Organigram had a negative trailing twelve-month return on equity of 6.00% and a negative net margin of 4.97%. What other stocks do shareholders of Organigram own? Based on aggregate information from My MarketBeat watchlists, some companies that other Organigram investors own include KushCo (KSHB), Auxly Cannabis Group (CBWTF), Supreme Cannabis (SPRWF), Medical Marijuana (MJNA), CNBX Pharmaceuticals (CNBX), MariMed (MRMD), Aurora Cannabis (ACB), EVIO (EVIO) and Gran Tierra Energy (GTE). What is Organigram's stock symbol? Organigram trades on the NASDAQ under the ticker symbol "OGI." Who are Organigram's major shareholders? Organigram's stock is owned by a number of institutional and retail investors. Top institutional investors include Mirae Asset Global Investments Co. Ltd. (0.81%), Intact Investment Management Inc. (0.42%), Renaissance Technologies LLC (0.35%), Dimensional Fund Advisors LP (0.31%), Swiss National Bank (0.21%) and Baader Bank Aktiengesellschaft (0.18%). How do I buy shares of Organigram? Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Organigram's stock price today? One share of OGI stock can currently be purchased for approximately $0.63. How much money does Organigram make? Organigram (NASDAQ:OGI) has a market capitalization of $198.66 million and generates $111.27 million in revenue each year. The company earns $-11,230,000.00 in net income (profit) each year or ($0.03) on an earnings per share basis. How many employees does Organigram have? The company employs 841 workers across the globe. How can I contact Organigram? Organigram's mailing address is 35 English Dr., Moncton Z4, E1E 3X3. The official website for the company is www.organigram.ca. The company can be reached via phone at (844) 644-4726. This page (NASDAQ:OGI) was last updated on 3/26/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.